Literature DB >> 17332371

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma.

Henrik Hjalgrim1, Karin Ekström Smedby, Klaus Rostgaard, Daniel Molin, Stephen Hamilton-Dutoit, Ellen T Chang, Elisabeth Ralfkiaer, Christer Sundström, Hans-Olov Adami, Bengt Glimelius, Mads Melbye.   

Abstract

Infectious mononucleosis (IM) has been associated with an increased risk of Hodgkin lymphoma (HL), implicating a role for Epstein-Barr virus (EBV) in HL development. Although essential to the understanding of the association, it has remained uncertain if the relationship is restricted to the EBV-positive subset of HL. We collected information on mononucleosis history and childhood socioenvironmental characteristics in a population-based study of 586 patients with classic HL and 3,187 controls in Denmark and Sweden. Tumor EBV status was established for 499 cases by immunohistochemistry and in situ hybridization techniques. Odds ratios (OR) for the relationship between HL risk and mononucleosis and other risk factors were estimated by logistic regression for HL in younger (18-44 years) and older (45-74 years) adults, overall and by tumor EBV status. All analyses were adjusted for country-specific measures of maternal education and mononucleosis history. IM was associated with an increased risk of EBV-positive [OR, 3.23; 95% confidence interval (95% CI) 1.89-5.55] but not EBV-negative HL (OR, 1.35; 95% CI, 0.86-2.14). Risk of EBV-positive HL varied with time since IM and was particularly pronounced in younger adults (OR, 3.96; 95% CI, 2.19-7.18). IM-associated lymphomas occurred with a median of 2.9 years (1.8-4.9 years) after infection. The EBV specificity of the IM association was corroborated by a case-case comparison of IM history between younger adult EBV-positive and EBV-negative HL patients (OR(IM EBV+ HL versus EBV- HL), 2.68; 95% CI, 1.40-5.12). We found further evidence that IM is associated only with EBV-positive HL. This finding is compatible with the notion that EBV-positive and EBV-negative HL may have different etiologies.

Entities:  

Mesh:

Year:  2007        PMID: 17332371     DOI: 10.1158/0008-5472.CAN-06-3566

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Soluble factors produced by activated CD4+ T cells modulate EBV latency.

Authors:  Noémi Nagy; Mónika Adori; Abu Rasul; Frank Heuts; Daniel Salamon; Dorina Ujvári; Harsha S Madapura; Benjamin Leveau; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Birth order and risk of non-hodgkin lymphoma--true association or bias?

Authors:  Andrew E Grulich; Claire M Vajdic; Michael O Falster; Eleanor Kane; Karin Ekstrom Smedby; Paige M Bracci; Silvia de Sanjose; Nikolaus Becker; Jenny Turner; Otoniel Martinez-Maza; Mads Melbye; Eric A Engels; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C H Chiu; Silvia Franceschi; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard K Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2010-08-18       Impact factor: 4.897

Review 3.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.

Authors:  Alex Reza Gholiha; Peter Hollander; Ingrid Glimelius; Gustaf Hedstrom; Daniel Molin; Henrik Hjalgrim; Karin E Smedby; Jamileh Hashemi; Rose-Marie Amini; Gunilla Enblad
Journal:  Blood Adv       Date:  2021-03-23

5.  Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation.

Authors:  Christina A Clarke; Sally L Glaser; Scarlett L Gomez; Sophia S Wang; Theresa H Keegan; Juan Yang; Ellen T Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

6.  Role for HLA in susceptibility to infectious mononucleosis.

Authors:  Paul J Farrell
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

7.  gamma-Herpesvirus-induced protection against bacterial infection is transient.

Authors:  Eric J Yager; Frank M Szaba; Larry W Kummer; Kathleen G Lanzer; Claire E Burkum; Stephen T Smiley; Marcia A Blackman
Journal:  Viral Immunol       Date:  2009-02       Impact factor: 2.257

Review 8.  Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  M Kamper-Jørgensen; K Rostgaard; S L Glaser; S H Zahm; W Cozen; K E Smedby; S Sanjosé; E T Chang; T Zheng; C La Vecchia; D Serraino; A Monnereau; E V Kane; L Miligi; P Vineis; J J Spinelli; J R McLaughlin; P Pahwa; J A Dosman; M Vornanen; L Foretova; M Maynadie; A Staines; N Becker; A Nieters; P Brennan; P Boffetta; P Cocco; H Hjalgrim
Journal:  Ann Oncol       Date:  2013-06-19       Impact factor: 32.976

9.  Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis.

Authors:  Alain Monnereau; Sally L Glaser; Clayton W Schupp; Karin Ekström Smedby; Silvia de Sanjosé; Eleanor Kane; Mads Melbye; Lenka Forétova; Marc Maynadié; Anthony Staines; Nikolaus Becker; Alexandra Nieters; Paul Brennan; Paolo Boffetta; Pierluigi Cocco; Ingrid Glimelius; Jacqueline Clavel; Henrik Hjalgrim; Ellen T Chang
Journal:  Blood       Date:  2013-09-09       Impact factor: 22.113

Review 10.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.